000			01917 a2200553 4500
005			20250515215505.0
264		0	_c20100617
008			201006s 0 0 eng d
022			_a1879-1891
024	7		_a10.1016/j.ajo.2009.12.038 _2doi
040			_aNLM _beng _cNLM
100	1		_aSato, Taku
245	0	0	_aCombined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy. _h[electronic resource]
260			_bAmerican journal of ophthalmology _cJun 2010
300			_a947-954.e1 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aBevacizumab
650	0	4	_aChoroid _xblood supply
650	0	4	_aChoroid Diseases _xdiagnosis
650	0	4	_aCombined Modality Therapy
650	0	4	_aFemale
650	0	4	_aFluorescein Angiography
650	0	4	_aHumans
650	0	4	_aInjections
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPeripheral Vascular Diseases _xdiagnosis
650	0	4	_aPhotochemotherapy
650	0	4	_aPhotosensitizing Agents _xtherapeutic use
650	0	4	_aPorphyrins _xtherapeutic use
650	0	4	_aRetreatment
650	0	4	_aRetrospective Studies
650	0	4	_aTomography, Optical Coherence
650	0	4	_aTreatment Outcome
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVerteporfin
650	0	4	_aVisual Acuity _xphysiology
650	0	4	_aVitreous Body
700	1		_aKishi, Shoji
700	1		_aMatsumoto, Hidetaka
700	1		_aMukai, Ryo
773	0		_tAmerican journal of ophthalmology _gvol. 149 _gno. 6 _gp. 947-954.e1
856	4	0	_uhttps://doi.org/10.1016/j.ajo.2009.12.038 _zAvailable from publisher's website
999			_c19707691 _d19707691